UK Biobank

The firms will have exclusive access for a limited time to the data from the first 50,000 individuals with samples in the biobank to be sequenced.

While the new methods were developed specifically to address the UKBB's needs, Affymetrix believes the approaches will set a precedent for industrial-scale genotyping.

The UK Biobank will use Trinean's technology to quantify molecules during the DNA extraction stage of a large genotyping project.

This article was originally posted on Oct. 25.
BOSTON – Customers who are interested in using Illumina's highest-content genotyping arrays will soon be able to do so at a reduced cost.

The UK Biobank and Affymetrix recently finished developing an array that will be used to genotype all 500,000 samples in UKBB's biorepository.

This story was originally posted on Aug. 1.
Affymetrix posted a 20 percent rise in second-quarter revenues last week, largely due to a contribution from its eBioscience business, but also driven by double-digit growth in genotyping array sales.

Name: Mark McCarthy
Title: Robert Turner Professor of Diabetes, University of Oxford

This article was originally posted on May 1.
An unanticipated decline in demand for gene expression microarrays has thwarted Affymetrix's return to growth and profitability and caused the firm to suspend its 2013 guidance, executives said last week.

Name: Andrew Brooks
Title: Chief operating officer, RUCDR Infinite Biologics

Affymetrix and the UK Biobank last week announced an agreement that will see the array vendor genotype UKBB's collection of 500,000 samples.

Pages

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.